GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we treat diabetes mellitus . These new therapies function to stimulating the body’s natural GLP-1 https://enrollbookmarks.com/story21670359/glp-1-a-significant-advance-in-blood-sugar-treatment